Abstract:Evidence continues to grow on potential health risks associated with Ginkgo biloba and its constituents. While biflavonoid is a subclass of the flavonoid family in Ginkgo biloba with a plenty of pharmacological properties, the potential toxicological effects of biflavonoids remains largely unknown. Thus, the aim of this study was to investigate the in vitro and in vivo toxicological effects of the biflavonoids from Ginkgo biloba (i.e., amentoflavone, sciadopitysin, ginkgetin, isoginkgetin, and bilobetin). In the in vitro cytotoxicity test, the five biflavonoids all reduced cell viability in a dose-dependent manner in human renal tubular epithelial cells (HK-2) and human normal hepatocytes (L-02), indicating they might have potential liver and kidney toxicity. In the in vivo experiments, after intragastrical administration of these biflavonoids at 20 mg·kg−1·d−1 for 7 days, serum biochemical analysis and histopathological examinations were performed. The activity of alkaline phosphatase was significantly increased after all the biflavonoid administrations and widespread hydropic degeneration of hepatocytes was observed in ginkgetin or bilobetin-treated mice. Moreover, the five biflavonoids all induced acute kidney injury in treated mice and the main pathological lesions were confirmed to the tubule, glomeruli, and interstitium injuries. As the in vitro and in vivo results suggested that these biflavonoids may be more toxic to the kidney than the liver, we further detected the mechanism of biflavonoids-induced nephrotoxicity. The increased TUNEL-positive cells were detected in kidney tissues of biflavonoids-treated mice, accompanied by elevated expression of proapoptotic protein BAX and unchanged levels of antiapoptotic protein BCL-2, indicating apoptosis was involved in biflavonoids-induced nephrotoxicity. Taken together, our results suggested that the five biflavonoids from Ginkgo biloba may have potential hepatic and renal toxicity and more attentions should be paid to ensure Ginkgo biloba preparations safety.

Biflavonoids from Ginkgo biloba leaves as a novel anti-atherosclerotic candidate: Inhibition potency and mechanistic analysis

Biflavones from Ginkgo biloba as inhibitors of human thrombin

Potential Hepatic and Renal Toxicity Induced by the Biflavonoids from Ginkgo Biloba.

Anti-atherosclerotic Effects and Molecular Targets of Ginkgolide B from Ginkgo Biloba

Abstract 3082: Isoginkgetin, A Bioactive Biflavonoid Isolated from Ginkgo Biloba, Reduces Atherosclerosis by Inhibiting Acly

Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism

Biflavonoids: Important Contributions to the Health Benefits of Ginkgo (Ginkgo biloba L.)

Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina

Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease

In Silico Analysis of the Biflavonoids As Novel Inhibitors of Α-Glucosidase

Evaluation of the anti-inflammatory properties of the active constituents in Ginkgo biloba for the treatment of pulmonary diseases.

Chemical Structures of 4-Oxo-flavonoids in Relation to Inhibition of Oxidized Low-Density Lipoprotein (Ldl)-Induced Vascular Endothelial Dysfunction

Coumaroyl and Feruloyl Flavonoid Glycosides from the Male Flowers of Ginkgo Biloba L. and Their Inhibitory Activity Against Α-Glucosidase

Preparation of a new component group of Ginkgo biloba leaves and investigation of the antihypertensive effects in spontaneously hypertensive rats

Theaflavin: a Natural Candidate to Restrain Thrombosis

Studies on the inhibition of α-glucosidase by biflavonoids and their interaction mechanisms

Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies

Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders

Inhibition of Ginkgo Flavones Against Aggregation and Fibrogenesis of Aβ_(1-42)

Discovery and Characterization of the Biflavones From Ginkgo biloba as Highly Specific and Potent Inhibitors Against Human Carboxylesterase 2

Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications